Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Jason Okazaki Gets 38,380 RSU Shares, Sells 6,202 to Cover Taxes

Assembly Biosciences CEO and President Jason A. Okazaki filed a Form 4 on November 3, 2026, reporting the acquisition of 38,380 shares of common stock through a performance-based restricted stock unit award and the mandatory sale of 6,202 shares to cover tax withholding obligations.

Anjali Anand | 03 November 2026

Gaggar Acquires 13,705 Shares, Sells 2,593 in Tax Cover

Assembly Biosciences Chief Medical Officer Anuj Gaggar filed a Form 4 on November 3, 2026, disclosing a performance-based restricted stock unit vesting event on October 30, 2026, followed by mandatory sell-to-cover share sales on November 2, 2026.

Shwetambri Chauhan | 03 November 2026

Suzanne Coulter Acquires 140.629 Phantom Stock Units in ANF

Director Suzanne M. Coulter of Abercrombie & Fitch Co /DE/ filed a statement of changes in beneficial ownership on November 3, 2026, disclosing the acquisition of phantom stock units on November 2, 2026.

Vinay Lochav | 03 November 2026

Bjorkquist Vests 3,840 Shares at Assembly Biosciences Oct 30

Jeanette M. Bjorkquist, Principal Financial Officer and Principal Accounting Officer of Assembly Biosciences, Inc. (NASDAQ:ASMB), filed a Form 4 on November 3, 2026, disclosing a performance-based restricted stock unit vesting event on October 30, 2026, and two sell-to-cover share sales on November 2, 2026.

Anjali Anand | 03 November 2026

Nicole White Receives 13,705 RSU Shares at Assembly Biosciences

Assembly Biosciences Chief Manufacturing Officer Nicole S. White filed a Form 4 on November 3, 2026, disclosing a performance-based restricted stock unit award settlement and mandatory sell-to-cover share sales on October 30 and November 2, 2026.

Manish Choudhary | 03 November 2026

Delaney Acquires 13,705 ASMB Shares via Performance RSU

William E. Delaney IV, Chief Scientific Officer of Assembly Biosciences, Inc., filed a Form 4 on November 3, 2026, disclosing the acquisition of 13,705 shares of common stock on October 30, 2026, following the achievement of a performance-based vesting condition.

Aakashdeep | 03 November 2026

Saba Capital Sells 86,172 ECAT Shares at $13.6

Saba Capital Management, L.P. filed a Form 4 with the SEC on November 3, 2026, disclosing a sale of common stock in BlackRock ESG Capital Allocation Term Trust on November 2, 2026.

Shwetambri Chauhan | 03 November 2026

CubeSmart CLO Foster Exercises 22,776 Options at $27.78

Jeffrey P. Foster, Chief Legal Officer and Secretary of CubeSmart, filed a Form 4 on November 3, 2026, disclosing a stock option exercise and same-day sale of 22,776 shares of common stock on November 2, 2026.

Shwetambri Chauhan | 03 November 2026

CubeSmart CFO Martin Exercises 36,765 Options at $26.30

CubeSmart CFO Timothy M. Martin filed a Form 4 on November 3, 2026, disclosing a same-day option exercise and sale of 36,765 shares of common stock on November 2, 2026.

Shwetambri Chauhan | 03 November 2026

CarGurus CPO Elshareef Sells 1,964 Shares on Nov 2

CarGurus, Inc. Chief Product Officer Ismail Elshareef filed a Form 4 on November 3, 2026, disclosing two transactions in Class A Common Stock on October 30 and November 2, 2026.

Nitish Kishor | 03 November 2026
Support

Hi! How can we help you today?

Loading…